Keeping up with Streptococcus pneumoniae in children living with HIV

Hugo Soudeyns^{1

2

3}, Caroline Quach^{1

2

3}

Affiliations

¹ Centre de recherche du CHU Sainte-Justine.
² Department of Microbiology, Infectiology & Immunology, Faculty of Medicine.
³ Department of Pediatrics, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

Comment

Hugo Soudeyns et al. AIDS. 2023.

. 2023 Jul 1;37(8):1325-1327.

doi: 10.1097/QAD.0000000000003544.

Hugo Soudeyns^{1

2

3}, Caroline Quach^{1

2

3}

¹ Centre de recherche du CHU Sainte-Justine.
² Department of Microbiology, Infectiology & Immunology, Faculty of Medicine.
³ Department of Pediatrics, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

No abstract available

Comment on

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV.
Wilck M, Barnabas S, Chokephaibulkit K, Violari A, Kosalaraksa P, Yesypenko S, Chukhalova I, Dagan R, Richmond P, Mikviman E, Morgan L, Feemster K, Lupinacci R, Chiarappa J, Madhi SA, Bickham K, Musey L; V114-030 Study Group. Wilck M, et al. AIDS. 2023 Jul 1;37(8):1227-1237. doi: 10.1097/QAD.0000000000003551. Epub 2023 Mar 17. AIDS. 2023. PMID: 36939067 Free PMC article. Clinical Trial.

1. Jallow S, Madhi SA. Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children . Expert Rev Vaccines 2017; 16:453–465.
1. Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Johnson C, Madore D, Hogerman D. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics . Pediatr Infect Dis J 1994; 13:368–372.
1. Siber GR. Pneumococcal disease: prospects for a new generation of vaccines . Science 1994; 265:1385–1387.
1. Mehr S, Wood N. Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination . Paediatr Respir Rev 2012; 13:258–264.
1. Weinberger R, von Kries R, van der Linden M, Rieck T, Siedler A, Falkenhorst G. Invasive pneumococcal disease in children under 16 years of age: incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in Germany . Vaccine 2018; 36:572–577.